W David Merryman Selected Research

5-HT2B Serotonin Receptor

1/2021	Targeting 5-HT2B Receptor Signaling Prevents Border Zone Expansion and Improves Microstructural Remodeling After Myocardial Infarction.
1/2020	Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
12/2018	Bone Marrow-Derived Proangiogenic Cells Mediate Pulmonary Arteriole Stiffening via Serotonin 2B Receptor Dependent Mechanism.
1/2016	Serotonin 2B Receptor Antagonism Prevents Heritable Pulmonary Arterial Hypertension.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

W David Merryman Research Topics

Disease

9	Aortic Valve Disease 01/2021 - 04/2014
7	Fibrosis (Cirrhosis) 01/2022 - 11/2011
4	Heart Diseases (Heart Disease) 01/2022 - 05/2015
3	Aortic Valve Stenosis (Aortic Stenosis) 01/2022 - 04/2019
2	Hypertrophy 01/2022 - 01/2022
2	Myocardial Infarction 01/2021 - 01/2019
2	Carcinoid Tumor (Carcinoid) 01/2020 - 11/2011
2	Mitral Valve Prolapse 03/2014 - 09/2012
1	Hypertension (High Blood Pressure) 01/2022
1	Osteoporosis 01/2022
1	Postmenopausal Osteoporosis 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 01/2022
1	Atherosclerosis 10/2021
1	Cicatrix (Scar) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Chronic Renal Insufficiency 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Rheumatoid Arthritis 01/2019
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2019
1	Inflammation (Inflammations) 01/2019
1	Pulmonary Arterial Hypertension 12/2018
1	Hypoxia (Hypoxemia) 12/2018
1	Pulmonary Hypertension 12/2018
1	Arthritis (Polyarthritis) 12/2018
1	Familial Primary Pulmonary Hypertension 01/2016
1	Cardiotoxicity 12/2015
1	Pathologic Processes 05/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Contracture 09/2012
1	Heart Valve Diseases (Valvular Heart Disease) 11/2011
1	Carcinoid Heart Disease 11/2011
1	Ventricular Remodeling 06/2007
1	Infarction (Infarctions) 06/2007

Drug/Important Bio-Agent (IBA)

7	osteoblast cadherinIBA 10/2021 - 01/2013
6	Pharmaceutical PreparationsIBA 01/2022 - 04/2014
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2015
4	5-HT2B Serotonin ReceptorIBA 01/2021 - 01/2016
2	CollagenIBA 01/2021 - 09/2012
2	Serotonin (5 Hydroxytryptamine)IBA 01/2020 - 11/2011
2	CateninsIBA 01/2020 - 06/2017
2	CytokinesIBA 12/2018 - 05/2013
1	TalinIBA 01/2022
1	Angiotensin IIIBA 01/2022
1	CholesterolIBA 01/2022
1	Therapeutic UsesIBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Glutamine (L-Glutamine)FDA Link 01/2021
1	MicroRNAs (MicroRNA)IBA 01/2020
1	FenfluramineIBA 01/2020
1	Long Noncoding RNAIBA 10/2019
1	Naproxen (Naprosyn)FDA LinkGeneric 04/2019
1	Celecoxib (Celebrex)FDA Link 04/2019
1	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2019
1	Ibuprofen (Motrin)FDA LinkGeneric 04/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Diphtheria ToxinIBA 12/2018
1	RNA (Ribonucleic Acid)IBA 12/2018
1	Semaxinib (SU5416)IBA 12/2018
1	Tamoxifen FDA LinkGeneric 12/2018
1	Biological ProductsIBA 12/2018
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2017
1	IntegrinsIBA 05/2015
1	Cadherins (E-Cadherin)IBA 05/2015
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2013
1	Serotonin ReceptorsIBA 11/2011
1	Urea (Carbamide)FDA LinkGeneric 06/2007
1	PolyestersIBA 06/2007
1	salicylhydroxamic acid (SHAM)IBA 06/2007
1	Urethane (Ethyl Carbamate)IBA 06/2007

Therapy/Procedure

4	Therapeutics 12/2021 - 09/2012
2	Radiofrequency Ablation 03/2014 - 09/2012
2	Catheters 03/2014 - 09/2012
1	Ovariectomy (Oophorectomy) 01/2022